|
| 34874550 | Testing for heterogeneity in the utility of a surrogate marker. | Biometrics | 2023 |
| 37556135 | Use the Receiver Operating Characteristic to Assess Model Accuracy-Reply. | JAMA Cardiol | 2023 |
| 37622748 | Hospitalizations during home-based walking exercise interventions in peripheral artery disease: Results from two randomized clinical trials. | Vasc Med | 2023 |
| 37733346 | Home-Based Walking Exercise and Supervised Treadmill Exercise in Patients With Peripheral Artery Disease: An Individual Participant Data Meta-Analysis. | JAMA Netw Open | 2023 |
| 37535885 | Evaluating the Duration of Response With Mirvetuximab Soravtansine for Treating Platinum-Resistant Ovarian Cancer. | J Clin Oncol | 2023 |
| 35426444 | Robust approach to combining multiple markers to improve surrogacy. | Biometrics | 2023 |
| 37342044 | Using a Clinically Interpretable End Point Composed of Multiple Outcomes to Evaluate Totality of Treatment Effect in Comparative Oncology Studies. | JAMA Netw Open | 2023 |
| 37010873 | Assessment of Median and Mean Survival Time in Cancer Clinical Trials. | JAMA Netw Open | 2023 |
| 36723915 | Quantifying and Interpreting the Prediction Accuracy of Models for the Time of a Cardiovascular Event-Moving Beyond C Statistic: A Review. | JAMA Cardiol | 2023 |
| 36653933 | On assessing survival benefit of immunotherapy using long-term restricted mean survival time. | Stat Med | 2023 |
| 36588397 | Medical therapies, comorbid conditions, and functional performance in people with peripheral artery disease enrolled in clinical trials between 2004 and 2021. | Vasc Med | 2023 |
| 36567551 | Cigarette smoking and mitochondrial dysfunction in peripheral artery disease. | Vasc Med | 2023 |
| 36892048 | Mitochondrial Complex Abundance, Mitophagy Proteins, and Physical Performance in People With and Without Peripheral Artery Disease. | J Am Heart Assoc | 2023 |
| 36150636 | Barriers to participation in supervised exercise therapy reported by people with peripheral artery disease. | J Vasc Surg | 2023 |
| 36372072 | Using a surrogate with heterogeneous utility to test for a treatment effect. | Stat Med | 2023 |
| 34446466 | Macrophage-derived IL-6 trans-signalling as a novel target in the pathogenesis of bronchopulmonary dysplasia. | Eur Respir J | 2022 |
| 38050638 | BOUNDS ON THE CONDITIONAL AND AVERAGE TREATMENT EFFECT WITH UNOBSERVED CONFOUNDING FACTORS. | Ann Stat | 2022 |
| 37645407 | Quantifying Treatment Effects in Trials with Multiple Event-Time Outcomes. | NEJM Evid | 2022 |
| 37981982 | A Composite Endpoint for Treatment Benefit According to Patient Preference. | Stat Biopharm Res | 2022 |
| 35572522 | Corrigendum: Distinct Age-Related Epigenetic Signatures in CD4 and CD8 T Cells. | Front Immunol | 2022 |
| 36533626 | Attendance at Supervised Exercise Sessions and Walking Outcomes in Peripheral Artery Disease: Results From 2 Randomized Clinical Trials. | J Am Heart Assoc | 2022 |
| 36275859 | Efficient Evaluation of Prediction Rules in Semi-Supervised Settings under Stratified Sampling. | J R Stat Soc Series B Stat Methodol | 2022 |
| 36300658 | Dysregulated Genes, MicroRNAs, Biological Pathways, and Gastrocnemius Muscle Fiber Types Associated With Progression of Peripheral Artery Disease: A Preliminary Analysis. | J Am Heart Assoc | 2022 |
| 36265267 | The effect of hyperoxia on ventilation during recovery from general anesthesia: A randomized pilot study for a parallel randomized controlled trial. | J Clin Anesth | 2022 |
| 35894088 | Effects of Walking Exercise at a Pace With Versus Without Ischemic Leg Symptoms on Functional Performance Measures in People With Lower Extremity Peripheral Artery Disease: The LITE Randomized Clinical Trial. | J Am Heart Assoc | 2022 |
| 36194220 | Effect of Telmisartan on Walking Performance in Patients With Lower Extremity Peripheral Artery Disease: The TELEX Randomized Clinical Trial. | JAMA | 2022 |
| 36053782 | Predictive signature development based on maximizing the area between receiver operating characteristic curves. | Stat Med | 2022 |
| 35980612 | Handling Informative Premature Treatment or Study Discontinuation for Assessing Between-Group Differences in a Comparative Oncology Trial. | JAMA Oncol | 2022 |
| 35191170 | Utilizing restricted mean duration of response for efficacy evaluation of cancer treatments. | Pharm Stat | 2022 |
| 34851356 | Practical Recommendations on Quantifying and Interpreting Treatment Effects in the Presence of Terminal Competing Risks: A Review. | JAMA Cardiol | 2022 |
| 35080625 | Evaluating Long-term Efficacy of Neoadjuvant Chemoradiotherapy Plus Surgery for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma. | JAMA Surg | 2022 |
| 34793926 | Identifying gaps in disease knowledge among patients with peripheral artery disease. | J Vasc Surg | 2022 |
| 34734980 | Analysis of Outcomes With Addition of Immunotherapy to Chemoradiation Therapy for Non-Small Cell Lung Cancer. | JAMA Oncol | 2022 |
| 31175828 | Multivariate meta-analysis model for the difference in restricted mean survival times. | Biostatistics | 2021 |
| 33829920 | Sustained physical activity in peripheral artery disease: Associations with disease severity, functional performance, health-related quality of life, and subsequent serious adverse events in the LITE randomized clinical trial. | Vasc Med | 2021 |
| 33877277 | Quantifying the Effect of Lower vs Higher Positive End-Expiratory Pressure on Ventilator-Free Survival in ICU Patients. | JAMA | 2021 |
| 33484978 | Cognitive impairment in Parkinson's disease is associated with Default Mode Network subsystem connectivity and cerebrospinal fluid Aβ. | Parkinsonism Relat Disord | 2021 |
| 33821898 | Effect of Low-Intensity vs High-Intensity Home-Based Walking Exercise on Walk Distance in Patients With Peripheral Artery Disease: The LITE Randomized Clinical Trial. | JAMA | 2021 |
| 34783094 | Choosing clinically interpretable summary measures and robust analytic procedures for quantifying the treatment difference in comparative clinical studies. | Stat Med | 2021 |
| 34799398 | Moving beyond conventional stratified analysis to assess the treatment effect in a comparative oncology study. | J Immunother Cancer | 2021 |
| 34075780 | Perceived Versus Objective Change in Walking Ability in Peripheral Artery Disease: Results from 3 Randomized Clinical Trials of Exercise Therapy. | J Am Heart Assoc | 2021 |
| 34060486 | Histone deficiency and accelerated replication stress in T cell aging. | J Clin Invest | 2021 |
| 34090987 | Effects of supervised exercise therapy on blood pressure and heart rate during exercise, and associations with improved walking performance in peripheral artery disease: Results of a randomized clinical trial. | J Vasc Surg | 2021 |
| 33053155 | Survival Analysis of Treatment Efficacy in Comparative Coronavirus Disease 2019 Studies. | Clin Infect Dis | 2021 |
| 33210329 | A likelihood ratio test on temporal trends in age-period-cohort models with applications to the disparities of heart disease mortality among US populations and comparison with Japan. | Stat Med | 2021 |
| 32920821 | Evaluating multiple surrogate markers with censored data. | Biometrics | 2021 |
| 32416309 | Clinical characteristics and response to supervised exercise therapy of people with lower extremity peripheral artery disease. | J Vasc Surg | 2021 |
| 32335305 | Meaningful change in 6-minute walk in people with peripheral artery disease. | J Vasc Surg | 2021 |
| 30945590 | Nonparametric estimation of risk tracking indices for longitudinal studies. | Stat Methods Med Res | 2020 |
| 32061098 | On the empirical choice of the time window for restricted mean survival time. | Biometrics | 2020 |